Daniela Purcea

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles et al. · New England Journal of Medicine · 2023 · 462 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer

Eija Lundström, Rupert K. Rencken, Johann H. van Wyk et al. · Clinical Drug Investigation · 2009 · 56 citations

Medicine, Oncology, Pharmacology +10

4 ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTS

Robert Flisiak, Jean–Michel Pawlotsky, R. Crabbé et al. · Journal of Hepatology · 2011 · 54 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty

Karen O. Klein, Joshua Yang, Javier Aisenberg et al. · Journal of Pediatric Endocrinology and Metabolism · 2016 · 40 citations

Medicine, Endocrinology, Pharmacotherapy +15

Debio0932, a second-generation oral heat shock protein (HSP) inhibitor, in patients with advanced cancer—results of a first-in-man dose-escalation study with a fixed-dose extension phase

Nicolás Isambert, Jean‐Pierre Delord, Jean‐Charles Soria et al. · Annals of Oncology · 2015 · 36 citations

Medicine, Oncology, Pharmacology +10